O. Yerushalmy

The paper evaluates phage inhalation delivery using a 3D airways model, showing variable titer reduction and no correlation with phage size or genome, emphasizing the need for personalized phage therapy.

The paper isolates and characterizes phages targeting MDR Providencia stuartii, showing they can eradicate 95% of tested strains and disrupt biofilms in a catheter model.

This paper proposes a framework for in vitro phage-antibiotic matching in clinical settings to support personalized phage therapy.